SKIN:NSD-Beauty Health Co (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 1.77

Change

-0.02 (-1.12)%

Market Cap

USD 0.21B

Volume

1.32M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
IPAR Inter Parfums Inc

-0.92 (-0.74%)

USD 3.88B
NWL Newell Brands Inc

-0.02 (-0.22%)

USD 3.13B
HELE Helen of Troy Ltd

-1.37 (-2.09%)

USD 1.48B
EWCZ European Wax Center Inc

-0.05 (-0.69%)

USD 0.43B
WALD Waldencast Acquisition Corp

-0.16 (-4.05%)

USD 0.42B
WALDW Waldencast Acquisition Corp

-0.01 (-7.95%)

USD 0.37B
HNST Honest Company Inc

-0.05 (-1.27%)

USD 0.36B
DSY Big Tree Cloud Holdings Limite..

-0.30 (-8.11%)

USD 0.24B
UG United-Guardian Inc

-0.29 (-2.09%)

USD 0.06B
RAY Raytech Holding Limited Ordina..

+0.04 (+2.86%)

USD 0.03B

ETFs Containing SKIN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.09% 64% D 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -43.09% 64% D 19% F
Trailing 12 Months  
Capital Gain -55.30% 36% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -55.30% 36% F 13% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -36.64% 9% A- 4% F
Dividend Return -36.64% 9% A- 4% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.08% 73% C 62% D
Risk Adjusted Return -121.80% 9% A- 2% F
Market Capitalization 0.21B 43% F 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector